跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,830 条关于
“Intra-Cellular”
全部
6,830
临床试验
4,197
药物
150
机构
28
资讯
2,455
去年
Johnson & Johnson Strengthens Neuroscience Portfolio with $14.6 Billion Intra-Cellular Acquisition
去年
Intra-Cellular's Caplyta Shows Strong Efficacy in Schizophrenia Relapse Prevention
去年
J&J Boosts Neuroscience Pipeline with ITCI Acquisition, FDA Approves Spravato Monotherapy for TRD
去年
Intra-Cellular Therapies Seeks FDA Approval for Caplyta in Major Depressive Disorder
去年
Caplyta Shows Positive Phase 3 Results for Schizophrenia Relapse Prevention
去年
Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6 Billion, Bolstering Neuroscience Portfolio
去年
Intra-Cellular Therapies Seeks FDA Approval for Caplyta as Adjunctive MDD Treatment
去年
J&J Raises 2025 Sales Forecast Despite $400M Tariff Impact Following Intra-Cellular Acquisition
去年
Vertex Records First Casgevy Sale, Intra-Cellular Therapies Reports Positive Caplyta Trial Results
去年
Lumateperone Shows Promise in Schizophrenia Relapse Prevention
第 1 页,共 246 页
上一页
下一页